Literature DB >> 16530844

A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies.

Raquel Bridi1, Fernanda U Fontella, Vânia Pulrolnik, César A Braun, Giovanni K Zorzi, Daniella Coelho, Moacir Wajner, Carmen Regla Vargas, Carlos Severo Dutra-Filho.   

Abstract

We report a chemically-induced model of maple syrup urine disease (MSUD) in 10- and 30-day-old rats produced by subcutaneous administration of a branched-chain amino acids (BCAA) pool along with the analyses of plasma and brain amino acid levels by HPLC at 0-120 min after administration. We observed an increase of plasma leucine (Leu), isoleucine (Ile) and valine (Val) concentrations in both 10- and 30-day-old rats. These increases were accompanied by a concomitant reduction of plasma concentrations of methionine (Met), phenylalanine (Phe), tyrosine (Tyr), histidine (His), alanine (Ala), lysine (Lys), and ornithine (Orn) in 10-day-old rats and of Met, Phe, Tyr, tryptophan (Trp), and Orn in 30-day-old rats. These results are similar to those observed in MSUD patients during crises, when plasma levels of large neutral amino acids (LNAA) are also reduced when BCAA concentrations are increased. In the brain, increased concentrations of Leu, Ile and Val were achieved in 10-day-old rats at all times after injection. In contrast, no differences in cerebral concentrations of BCAA were observed in 30-day-old rats. In conclusion, the present MSUD model, using 10- rather than 30-day-old rats, has a similar amino acid profile to that of MSUD untreated patients and is suitable to investigate the mechanisms of brain damage characteristic of this disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530844     DOI: 10.1016/j.jneumeth.2006.01.005

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  18 in total

1.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

2.  Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.

Authors:  Giselli Scaini; Meline O S Morais; Camila B Furlanetto; Luiza W Kist; Talita C B Pereira; Patrícia F Schuck; Gustavo C Ferreira; Matheus A B Pasquali; Daniel P Gelain; José Cláudio F Moreira; Maurício R Bogo; Emilio L Streck
Journal:  Neurochem Res       Date:  2015-02-14       Impact factor: 3.996

3.  The intra-hippocampal leucine administration impairs memory consolidation and LTP generation in rats.

Authors:  Viviane Glaser; Valeria P Carlini; Laura Gabach; Marisa Ghersi; Susana Rubiales de Barioglio; Oscar A Ramirez; Mariela F Perez; Alexandra Latini
Journal:  Cell Mol Neurobiol       Date:  2010-06-26       Impact factor: 5.046

4.  Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.

Authors:  Luciana Rosa; Leticia S Galant; Dhébora M Dall'Igna; Janaina Kolling; Cassiana Siebert; Patrícia F Schuck; Gustavo C Ferreira; Angela T S Wyse; Felipe Dal-Pizzol; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.590

5.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

6.  Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.

Authors:  Emilio L Streck; Felipe P Bussular; Leticia B Wessler; Mariane B Duarte; Victoria L Rezende; Matheus S Rodrigues; Carolina A Torres; Isabela S Lemos; Gabriela Candiotto; Fernanda F Gava; Jade de Oliveira; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2020-10-24       Impact factor: 3.584

7.  Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.

Authors:  Giselli Scaini; Clarissa M Comim; Giovanna M T Oliveira; Matheus A B Pasquali; João Quevedo; Daniel P Gelain; José Cláudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Maurício R Bogo; Emilio L Streck
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

8.  Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.

Authors:  Giselli Scaini; Lis Mairá Mello-Santos; Camila B Furlanetto; Isabela C Jeremias; Francielle Mina; Patrícia F Schuck; Gustavo C Ferreira; Luiza W Kist; Talita C B Pereira; Maurício R Bogo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-04-05       Impact factor: 5.590

9.  Chemically induced acute model of sarcosinemia in wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2015-11-12       Impact factor: 3.584

10.  Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.

Authors:  César A Ribeiro; Angela M Sgaravatti; Rafael B Rosa; Patrícia F Schuck; Vanessa Grando; Anna L Schmidt; Gustavo C Ferreira; Marcos L S Perry; Carlos S Dutra-Filho; Moacir Wajner
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.